4//SEC Filing
Miller Aine 4
Accession 0002012524-25-000006
CIK 0001583107other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 6:15 PM ET
Size
4.9 KB
Accession
0002012524-25-000006
Insider Transaction Report
Form 4
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
Transactions
- Tax Payment
Ordinary Shares
2025-11-20$17.90/sh−6,989$125,103→ 201,012 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0002012524
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 6:15 PM ET
- Size
- 4.9 KB